EyePoint Pharmaceuticals, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
Location
480 Pleasant Street, Suite B300, Watertown, MA

Insiders trading volume in the past year

EyePoint Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $103M May 6, 2024
EW Healthcare Partners, L.P. Other*, 10%+ Owner $87.3M Sep 1, 2023
Ocumension Therapeutics Director $2.51M Jan 11, 2024
Ye Liu Director $2.51M Jan 11, 2024
Nancy Lurker Director $2.03M Jul 10, 2025
David Scott Jones SVP & Chief Commercial Officer $1.44M Feb 9, 2024
Dario A. Paggiarino Chief Medical Officer $1.39M Mar 30, 2024
George Elston Chief Financial Officer $989K Sep 19, 2025
Michael Craig Pine Chief Corp Dev.&Strat. Officer $965K Jan 5, 2024
Jay S. Duker President and CEO, Director $696K Jul 10, 2025
Ramiro Ribeiro Chief Medical Officer $512K Jan 3, 2025
Karen L. Zaderej Director $248K +$113K +84.2% Jul 11, 2025
Douglas Godshall Director $201K Jun 22, 2021
John B. Landis Director $186K Jan 3, 2025
Ando Goran Director $105K Jan 3, 2025
Wendy F. Dicicco Director $77.6K Jan 3, 2025
Anthony P. Adamis Director $61.8K Jun 23, 2024
David R. Guyer Director $18.6K Jul 12, 2024
Stuart Duty Director Jan 3, 2025
Reginald J. Sanders Director Jan 8, 2025
Fred Hassan Director Jan 3, 2025
Adage Capital Management, L.P. 10%+ Owner Apr 18, 2024

Recent Insider Transactions by Companies or Individuals for EyePoint Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.